Restricted Research - Award List, Note/Discussion Page
Fiscal Year: 2023
2799 University of Houston-Clear Lake (144687)
Principal Investigator: Malin, David Herbert
Total Amount of Contract, Award, or Gift (Annual before 2011): $ 24,109
Exceeds $250,000 (Is it flagged?): No
Start and End Dates: 3/22/22 - 7/17/24
Restricted Research: YES
Academic Discipline: Psychology
Department, Center, School, or Institute: College of Human Sciences and Humanities
Title of Contract, Award, or Gift: Evaluating the Effect of Certain Drugs on Off-Label Medical Conditions
Name of Granting or Contracting Agency/Entity:
Acadia Pharmaceuticals
CFDA: N/A
Program Title: N/A
Note:
The overall purpose of these studies is to explore potential applications of pimavanserin to widespread biobehavioral problems such as opiate and nicotine withdrawal and post-traumatic stress disorder. NOTE: Incremental funding entered in 2019 for multi-year award. SAM 1.1.7. (Industrial collaboration for R&D) Previous Award List Number: 83873 Previous Award Determination Year: 2020
Discussion: No discussion notes